Conference Presentations

Oral Presentations

Apr 27-29 2018 Canadian Association for HIV Research (Vancouver, BC)

  • Prevention and Care Cascade for Hepatitis C among people who inject drugs in British Columbia, Canada
  • Population-level cascade of care for Hepatitis C among people living with and without HIV infection
  • Identifying 'Core Area' of HCV in British Columbia, Canada

Feb 9-11 2018 Canadian Liver Meeting (Toronto, On)

  • Real-world effectiveness of sobosbuvir- based regimens for treatment among people who inject drugs and those in Opioid substitution therapy in Canada
  • Hepatitis C Care Cascade in BC: Differences over time, by sex and birth cohort
  • The Cascade of HCV care


Apr 19-23 2017  International Liver Congress (Amsterdam,Netherlands)

  • Are DAAs reducing the barrier for Hive Co-infected and people who inject drugs? A population based cohort study
  • The impact of sustained virological respnse on long term risk of decompensated cirrhosis: The BC Hepatitis Testers Cohort

Apr 6-9 2017 Canadian Association for HIV research (Montreal,QU)

  • Factors determining HIV Risk among HCV infected individuals: The British Columbia Hepatitis Testers Cohort (BCHTC)
  • Shift in disparities in Hepatitis C treatment from interferon to DAA era: A population-based cohort study
  • Role of opoid substitution therapy and mental health counseling in preventing hepatitis C reinfection
  • A syndemic Approach to Assess the Effect of substance use and Social Disparities on the evolution of HIV/HCV infections in British Columbia
  • The impact of sustained viroogical response to HCV on long term risk of decompensated cirrhosis: The BC Hepatitis Testers C

Dec 6-8th, 2016 Canadian Immunization Conference (Ottawa)

  • Non-influenza Respiratory Virus (NIRV) Detections in a Sentinel Surveillance Platform, Canada 201-11 to 2017-15
  • Variable Effects of Repeat Vaccinations against Influenza (H3N2) Illness by Season 201-11 to 2014-15

Nov 11-15,2016 AASLD Annual Liver Meeting  (Boston, MA)

  • Impact of drug use and opioid  substitution therapy on hepatitis C reinfection   Presentation Link
  • Long-term effect of sustained virological response on hepatocellular carcinoma risk in Canadians with hepatitis C virus infection   View Poster

May 12-15, 2016 – Canadian Association for HIV Research (Winnipeg, MB)

  • The British Columbia Hepatitis Testers Cohort
  • Timing of Hepatitis B and C Diagnosis Relative to Hepatocellular Carcinoma Diagnosis in the BC Hepatitis Testers Cohort (BC-HTC)

Mar 30 - Apr 2, 2016 AMMI Canada - CACMID Annual Conference (Vancouver, BC)

  • Hepatitis C Virus (HCV) Mortality Patterns in the British Columbia Hepatitis Testers Cohort (BC-HTC)

Nov, 17 2015 AASLD Annual Liver Meeting (San Francisco, CA)

  • Hepatitis C Virus (HCV) Mortality Patterns in the British Columbia Hepatitis Testers Cohort (BC-HTC)
  • Timing of Hepatitis B and C Diagnosis Relative to Hepatocellular Carcinoma Diagnosis in the BC Hepatitis Testers Cohort (BC-HTC)

May, 29 2015 Hepatology Update (Toronto, ON)

  • The Epidemiology of HCV in Canada

Apr, 28 2014 International Health Data Linkage Conference (Vancouver, BC)

  • British Columbia Hep C-HIV Testers Cohort: A Linkage to Monitor Hepatitis C-Related Outcomes

Poster Presentations

Apr 27-29 2018 Canadian Association for HIV Research (Vancouver, BC)

  • Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection: a large population based study
  • Population-level cascade of care for Hepatitis C in British Columbia: Differences over time, by gender and birth cohort

Mar 22-2 2018 International Workshop on HIV and Hepatitis Observational Databases (Fuengirola, Spain)

  • Trends in decompensated cirrhosis and hepatocellular carcinoma in people with and without hepatitis C in British Columbia
  • Prevention and care cascade for hepatitis C among people who inject drugs in British Columbia, Canada

Feb 9-11 2018 Canadian Liver Meeting (Toronto, On)

  • Real-world Effectiveness of Sofosbuvir-based regimens for Treatment of Hepatitis C Genotypes 1-3: BC Hepatitis Testers Cohort (BC-HTC)
  • Spatial analysis of HCV infection in British Columbia, Canada
  • What is Killing People with HCV Infection? Analysis of a population-based cohort in Canada
  • Psychotherapy reduces the risk of HCV Sero-conversion among multi-testers from BC Hepatitis testers cohort

Oct 20-24 2017  AASLD Annual Liver Meeting  (Washington, D.C)

  • Real-world Effectiveness of Sofosbuvir-based regimens for Hepatitis C Treatment among People who inject Drugs and those in Opioid substitution Therapy in Canada
  • Real-world Effectiveness of Sofosbuvir-based Regimens for treatment of Hepatitis C Genotypes 1-3: BC Hepatitis Testers Cohort (BCHTC)
  • Adherence to sofosbuvir and ledipasvir-sofosbuvir in British Columbia
  • What is Killing People with HCV infection? Analysis of population based cohort in Canada

Sept 6-8, 2017 International Symposium on Hepatitis Care in Substance Users (INSHU) (New Jersery, USA)

  • Hepatitis C Virus (HCV) Mortality attribution by birth cohort: British Columbia Hepatitis Testers Cohort (BCHTC)

May 14-17, 2017 Harm Reduction Conference (Montreal,QU)

  • Hepatitis C treatment access to direct-acting antivirals among people who inject drugs and are on opioid substitution therapy

Apr 6-9th 2017 Canadian Association for HIV Research (Montreal,QU)

  • Hepatitis C re-clearance and lack of cross-genotype immunity in a large population cohort
  • Spatial and temporal trends of HIV and HCV diagnoses in British Columbia

Feb 13-16, 2017 Conference on Retrovirus and Opportunistic Infections (Seattle, WA)

  • Effects of OST and psychotherapy on HIV risk among HCV infected individuals
  • Risk profiles in mono infected TB patients and those co-infected with HCV and/or HIV

Dec 6-8th, 2016 Canadian Immunization Conference (Ottawa)

  • Variable effects of Repeat Vaccination against Influenza b Illness by Season 2010-11 to 2014-15

Nov 11-15,2016 AASLD Annual Liver Meeting  (Boston, MA)

  • Role of primary T-cell immunodeficiency and Hepatitis B co-infection on spontaneous clearance of Hepatitis C: The BC Hepatitis Testers Cohort
  • Re-clearance of hepatitis C: Role of  previous clearance and reinfection with a heterologous genotype
  • Social disparities and co-evolution of HIV/HCV infections,mental disorders and substance use: the British Columbia Hepatitis Testers Cohort
  • Impact of treatment induced vs spontaneous HCV clearance on the long term risk of hepatocellular carcinoma; BC Hepatitis Testers Cohort  View Poster

May 12-15, 2016 – Canadian Association for HIV Research (Winnipeg, MB)

  • Assessing Injection Drug Use from Diagnostic Codes in Administrative Healthcare Data: the British Columbia Hepatitis Testers Cohort

Feb, 26 2016 5th Canadian Symposium on HCV (Montréal, QC)

  • The BC Hepatitis Testers Cohort (BC-HTC): the population-level hepatitis C Cascade of Care, BC, Canada, 1992-2012

Mar 2, 2015 Canadian Association for the Study of the Liver (Banff, AB)

  • Hepatitis C Epidemiology in British Columbia to Inform Screening and Treatment Response